Orison Pharma International Group
Orison Pharma International Group is a privately held Indian pharmaceutical manufacturer, founded in 2002 and headquartered in Kala Amb, Himachal Pradesh, that produces affordable medicines for domestic and international markets, employing 501-1,000 staff.
- Company typePrivate
- Founded2002
- HeadquartersKala Amb, India
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Orison Pharma International Group does
Orison Pharma International Group is a privately held pharmaceutical manufacturer headquartered in Kala Amb, Himachal Pradesh, India. The company's stated focus is on producing affordable medicines and operating to ethical practices, positioning it within India's broad generic-pharma manufacturing base. Kala Amb sits in a Himachal Pradesh industrial zone that has historically attracted drug manufacturers due to tax incentives and a clustered supplier ecosystem, which is consistent with the firm's location choice.
The company was founded in 2002 and operates at a mid-tier scale of 501-1,000 employees, suggesting established manufacturing, quality control, and commercial functions, although specific products, therapeutic areas, dosage forms, regulatory approvals, and customer segments were not disclosed in the available sources. The "International Group" suffix in the corporate name signals an intent to participate in cross-border pharmaceutical trade, but no specific export markets, partner geographies, or international registrations were documented.
The revenue model was not disclosed. As a manufacturer of affordable medicines, plausible revenue mechanics include contract manufacturing, third-party / branded generics distribution, institutional or government tender supply, and export sales, but no pricing, channel, or customer-mix data is available to confirm any of these. Operationally, the company remains largely opaque from public sources: its website returned only a CAPTCHA/verification page, and no management team, funding history, certifications, or strategic milestones are on record in the input data.
Orison Pharma International Group firmographics
Firmographics- Name
- Orison Pharma International Group
- Website
- https://opigroup.org
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Orison Pharma International Group is a privately held Indian pharmaceutical manufacturer, founded in 2002 and headquartered in Kala Amb, Himachal Pradesh, that produces affordable medicines for domestic and international markets, employing 501-1,000 staff.
- Ownership category
- akta.pro rank
Orison Pharma International Group industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)
Keywords
Where Orison Pharma International Group is headquartered
LocationHeadquarters
- HQ city
- Kala Amb
- HQ country
- India
- HQ region
- Asia
Markets served
Orison Pharma International Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations
Orison Pharma International Group product offering
Product offeringCore offering
Orison Pharma International Group manufactures pharmaceuticals with a focus on affordable medicines and ethical practices. The company is headquartered in Kala Amb, India, was founded in 2002, and employs 501-1,000 people. Detailed product, pricing, and distribution information was not available from the source material.
Differentiator
Problem solved
Functional benefit
Orison Pharma International Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Orison Pharma International Group partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights2 records
Orison Pharma International Group competitors and assessment
Company assessmentBroad incumbents
- Lupin: India-based generic pharmaceutical manufacturer with a portfolio spanning formulations, APIs, and biosimilars. Directly comparable vertically integrated Indian generics peer.
- Cipla: Indian pharmaceutical major with a strong generics and complex generics franchise across respiratory, HIV, and chronic therapy areas. Directly comparable as a large Indian affordable-medicines manufacturer serving global markets.
- Sun Pharmaceutical Industries: India's largest specialty generics manufacturer with a global supply network and USFDA-approved plants. Comparable as a top-tier Indian affordable-medicines producer and likely direct competitor in domestic generic markets.
- Aurobindo Pharma: One of India's largest generic pharmaceutical manufacturers with a broad API-to-finished dosage portfolio and large US/Europe regulated market presence. Comparable to Orison as another India-based generics manufacturer targeting affordable medicine, though at substantially greater scale.
- Dr. Reddy's Laboratories: Indian pharma company with substantial generics, biosimilars, and API manufacturing operations. Comparable as another India-based affordable-medicines producer with strong regulated-market exposure.
Regional players
- TTK Healthcare: Indian pharmaceutical and consumer healthcare manufacturer with a domestic-led generics and OTC presence. Comparable as an India-based mid-sized pharma manufacturer focused on affordable products.
Direct peers
- Alkem Laboratories: Mid-to-large Indian generic pharmaceutical manufacturer with a portfolio in acute and chronic therapy areas and domestic + international distribution. Closely comparable to Orison in being a private/public Indian generics company with similar therapeutic breadth.
- Mankind Pharma: Indian pharma company built on an affordable-medicines value proposition with a heavy domestic franchise. Directly comparable to Orison's stated positioning around affordable medicines in India, though at considerably larger scale.
- Morepen Laboratories: Indian pharmaceutical manufacturer with a focus on APIs and finished dosage forms, supplying both domestic and export markets. Directly comparable as an India-based mid-sized generics manufacturer with an affordable-medicines portfolio.
- Ind-Swift Laboratories: India-based API and generic formulation manufacturer serving domestic and international markets. Comparable as a mid-sized Indian pharma manufacturer in the affordable-generics segment.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
Orison Pharma International Group social profiles
Digital presenceOrison Pharma International Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Orison Pharma International Group leadership team
Management profileNumber of profiles
Orison Pharma International Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Orison Pharma International Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Orison Pharma International Group
What does Orison Pharma International Group do?
Orison Pharma International Group manufactures pharmaceuticals with a focus on affordable medicines and ethical practices. The company is headquartered in Kala Amb, India, was founded in 2002, and employs 501-1,000 people. Detailed product, pricing, and distribution information was not available from the source material.
Is Orison Pharma International Group a public or private company?
Orison Pharma International Group is a private company. It is classified as unknown and is currently operating.
When was Orison Pharma International Group founded?
Orison Pharma International Group was founded in 2002. It employs 101 to 250 people.
Where is Orison Pharma International Group based?
Orison Pharma International Group is headquartered in Kala Amb, India, in the Asia region.
Who are Orison Pharma International Group's main competitors?
Broad incumbents on record are Lupin, Cipla, Sun Pharmaceutical Industries, Aurobindo Pharma and Dr. Reddy's Laboratories. TTK Healthcare is listed as a regional player. Direct peers are Alkem Laboratories, Mankind Pharma, Morepen Laboratories and Ind-Swift Laboratories.
Does Orison Pharma International Group have an API?
No public API is recorded for Orison Pharma International Group.
What industry is Orison Pharma International Group in?
Orison Pharma International Group's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO). Its NAICS code is 325412 and its SIC code is 2834.